$3.2 million per dose of Elevidys fails to meet primary endpoint in phase 3 trial
Primary endpoint and key functional secondary endpoints. Credit: Natural medicine (2024). DOI: 10.1038/s41591-024-03304-z According to the results published in Natural ...